Schistosomiasis haematobia: Histopathological course determined by cystoscopy in a patient in whom praziquantel treatment failed

15Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

Schistosomiasis haematobia or urinary schistosomiasis is one of the main public health problems in Africa and the Middle East. A single dose of 40 mg praziquantel per kg body weight continues to be the treatment of choice for this infection. The aims of this follow-up were to study the post-treatment course of a patient infected with S. haematobium and not submitted to re-exposure, and to identify complications of the disease and/or therapeutic failure after praziquantel treatment by histopathological analysis. Treatments were repeated under medical supervision to ensure the correct use of the drug. In view of the suspicion of lesions in cystoscopy, the patient was submitted to bladder biopsy. The histopathological characteristics observed in biopsies obtained, after each treatment, indicated viability of parasite eggs and activity of granulomas.

Cite

CITATION STYLE

APA

Da Silva, I. M., Pereira Filho, E., Thiengo, R., Ribeiro, P. C., Conceição, M. J., Panasco, M., & Lenzi, H. L. (2008). Schistosomiasis haematobia: Histopathological course determined by cystoscopy in a patient in whom praziquantel treatment failed. Revista Do Instituto de Medicina Tropical de Sao Paulo, 50(6), 343–346. https://doi.org/10.1590/S0036-46652008000600006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free